|
Martin Mackay
David Reid
Margaret M. Foran
Douglas E. Giordano
J. Kevin Buchi
Robert J. Cruikshank
James A. Thomson, Ph.D.
Martin Mackay
Senior Vice President; President, Pfizer Global Research & Development (PGRD)
Pfizer Inc.
Martin Mackay was appointed to the Board of Directors in April 2008. Dr. Mackay currently serves as Senior Vice President; President, Pfizer Global Research & Development (PGRD) since October 2007. Early in 2007, he was named Vice President PGRD, Head of Worldwide Development. From 2003 to 2007, he held the position of Senior Vice President, Head of Worldwide Research and Technology. From 1999 to 2003, he was the Senior Vice President, Head of Worldwide Discovery. In 1998, he held the position of Vice President, UK Discovery and, in 1997, he was the Senior Director, Head of Biology. Dr. Mackay, a member of the Pfizer Executive Leadership Team, joined Pfizer in 1995.
(back to top)
David Reid
Senior Vice President and Managing Director, Legal Division
Pfizer Inc.
David Reid was appointed to the Board of Directors in April 2008. Mr. Reid currently serves as Senior Vice President and Managing Director, Pfizer Inc.’s Legal Division and, from March 2008, Pfizer's acting interim General Counsel. Mr. Reid has lead the Licensing, Mergers and Acquisitions and Antitrust Center of Excellence in Pfizer’s Legal Division since 2003 and oversees a number of other functions. Prior to joining Pfizer in 1997, he was a partner at the law firm of Allen & Overy.
(back to top)
Margaret M. Foran
Senior Vice President, Corporate Governance, Associate General Counsel and Corporate Secretary
Pfizer Inc.
Margaret Foran was appointed to the Board of Directors in April 2008. Ms. Foran currently serves as Senior Vice President, Corporate Governance, Associate General Counsel and Corporate Secretary, Pfizer since August 2005. Previously Ms. Foran held the position of Vice President, Corporate Governance and Secretary at Pfizer from July 1997 to August 2005. She was Associate General Counsel and Assistant Secretary at III Corporation from July 1996 to July 1997 and served as Vice President, Assistant General Counsel and Assistant Secretary at J. P. Morgan & Co. from December 1984 to July 1996. Ms. Foran is a former director of MONY Life Insurance Company and received her B.A. and J.D. from the University of Notre Dame.
(back to top)
Douglas E. Giordano
Vice President, Worldwide Business Development
Pfizer Inc.
Douglas Giordano was appointed to the Board of Directors in April 2008. Mr. Giordano currently serves as Vice President, Worldwide Business Development, Pfizer since April 2007; Vice President, US Planning and Business Development, Pfizer, July 2005-March 2007; Senior Director/Team Leader, US Planning and Business Development, Pfizer, January 2003-June 2005; Director/Team Leader, US Planning and Business Development, Pfizer, January 2000-December 2002.
(back to top)
J. Kevin Buchi
Senior Vice President, Finance And Chief Financial Officer
Cephalon Inc.
J. Kevin Buchi was elected to serve as a member of the board of directors in June 2004. He has served as Senior Vice President, Finance and Chief Financial Officer of Cephalon, Inc. since April 1996, and previously held several financial positions with Cephalon, including Controller, since joining the company in March 1991. Cephalon, a Nasdaq-traded company, discovers, develops and markets innovative products to treat neurological and sleep disorders, cancer and pain. At Cephalon, Mr. Buchi has been involved in raising significant working capital through secondary debt offerings, convertible preferred stock and debt, bank debt, private placements/structural financing and derivative strategies. He is also involved with the acquisitions of product and companies, as well as developing and executing growth strategies. He previously worked at E.I. duPont de Nemours and Company, at PricewaterhouseCoopers as a senior auditor and at Eastman Kodak Co. as a production chemist. Mr. Buchi is also a director of Lorus Therapeutics, a for-profit biotechnology company. He is a graduate of Cornell University with a BA in Chemistry and a minor in Economics, and holds an MBA from Kellogg Graduate School of Management at Northwestern University. He is also a Certified Public Accountant.
(back to top)
Robert J. Cruikshank
Retired Senior Partner
Deloitte & Touche LLP
Robert J. Cruikshank has served as a member of the board of directors since May 1993. Mr. Cruikshank was a senior partner at Deloitte & Touche LLP from 1989 until retiring in March 1993. Mr. Cruikshank was a partner, office managing partner and member of the board of directors of the predecessor firms to Deloitte & Touche LLP in Houston from 1968 until 1989. He is a trustee of the Ray C. Fish Foundation and Texas Medical Center. He also serves as a director of Reliant Energy Incorporated, MAXXAM Incorporated, Kaiser Aluminum Corporation, Weingarten Realty Investors and as an advisory board member of Compass Bank of Houston. Mr. Cruikshank is a past chairman of the American Heart Association, is active at the affiliate levels and is a past Regent of the University of Texas System. Mr. Cruikshank received a B.A. in economics and accounting from Rice University and completed the Advanced Management Program at Harvard University.
(back to top)
James A. Thomson, Ph.D.
President And Chief Executive Officer
Rand Corporation
James A. Thomson, Ph.D. has served as a member of the board of directors since May 1994. He has been President and Chief Executive Officer of the RAND Corporation since 1989 and has served the institution in a variety of roles beginning in 1981. The RAND Corporation is a non-profit institution that seeks to improve public policy through research analysis in such areas as national defense, education and health. He also serves as a director of AK Steel Holding Co. From 1977 until 1981, he served on the National Security Council, at the White House. From 1974 until 1977, Dr. Thomson served as an operations research analyst in the Office of the Secretary of Defense, the Pentagon. Dr. Thomson is the author of numerous scholarly articles and reports on defense and scientific subjects. Dr. Thomson graduated from the University of New Hampshire in 1967 and received an M.S. and Ph.D. in Physics from Purdue University.
(back to top)
|
